Occupational therapists need to be able to evaluate the profession's interventions critically: to stop the ineffective, to reduce the hazardous and to promote the effective. Randomised controlled trials are a research tool for testing the efficacy of interventions with small to moderate effects. This review aims to cover the issues to be considered when designing a randomised controlled trial of complex interventions, such as occupational therapy.
Get full access to this article
View all access options for this article.
References
1.
AndresenEVahleVLollarD (2001) Proxy reliability: Health-related quality of life (HRQoL) measures for people with disability. Quality of Life Research, 10(7), 609–19.
2.
BerglandAJarnloGBLaakeK (2003) Predictors of falls in the elderly by location. Aging — Clinical and Experimental Research, 15(1), 43–50.
3.
Central Office for Research Ethics Committees (2005) Available at: http://www.corec.org.uk Accessed on 09.02.05.
4.
ChalmersTCelanoPSacksHSmithH (1983) Bias in treatment assignment in controlled clinical trials. New England Journal of Medicine, 309(22), 1358–61.
5.
ClemsonLCummingRGKendigHSwannMHeardRTaylorK (2004) The effectiveness of a community-based program for reducing the incidence of falls in the elderly: A randomised trial. Journal of the American Geriatric Society, 52(9), 1487–94.
Current Controlled Trials (2005) International Standard Randomised Controlled Trial Number Register. Available at: http://www.controlled-trials.com Accessed on 09.02.05.
8.
De AmiciDKlersyCRamajoliFBrustiaLPolitiP (2000) Impact of the Hawthorne effect in a longitudinal clinical study: The case of anaesthesia. Controlled Clinical Trials, 21(2), 103–14.
9.
DeaneKHO (2006) Randomised controlled trials: Part 2, reporting. British Journal of Occupational Therapy, 69, in press.
10.
DeaneKHOJonesDClarkeCEPlayfordDBen-ShlomoY (2001) Physiotherapy for Parkinson's disease (Cochrane review). The Cochrane Library. Oxford: Update Software. 3: CD002817.
11.
DeaneKHOEllis-HillCJonesDWhurrRBen-ShlomoYPlayfordEDClarkeCE (2002) Systematic review of paramedical therapies for Parkinson's disease. Movement Disorders, 17(5), 984–91.
12.
DeaneKHOEllis-HillCDekkerKDaviesPClarkeCE (2003) A survey of current occupational therapy practice for Parkinson's disease in the United Kingdom. British Journal of Occupational Therapy, 66(5), 193–200.
DevaneDBegleyCMClarkeM (2004) How many do I need? Basic principles of sample size estimation. Journal of Advanced Nursing, 47(3), 297–302.
15.
DevereauxPJMannsBJGhaliWAQuanHLacchettiCMontoriVMBhandariMGuyattGH (2001) Physician interpretations and textbook definitions of blinding terminology in randomised controlled trials. Journal of the American Medical Association, 285(15), 2000–2003.
16.
DorevitchMICossarRMBaileyFJBissetTLewisSJWiseLAMacLennanWJ (1992) The accuracy of self and informant ratings of physical functional capacity in the elderly. Journal of Clinical Epidemiology, 45(7), 791–98.
17.
ErnstEReschK (1995) Concept of true and perceived placebo effects. British Medical Journal, 311, 551–53.
18.
GaudetP (2002) Measuring the impact of Parkinson's disease: An occupational therapy perspective. Canadian Journal of Occupational Therapy, 69(2), 104–13.
19.
HarrisonJEPrestonSBluntSB (2000) Measuring symptom change in patients with Parkinson's disease. Age and Ageing, 29(1), 41–45.
20.
HoldenJD (2001) Hawthorne effects and research into professional practice. Journal of Evaluation in Clinical Practice, 7(1), 65–70.
21.
HydeP (2004) Fool's gold: Examining the use of gold standards in the production of research evidence. British Journal of Occupational Therapy, 67(2), 89–94.
22.
JenkinsonCPetoVFitzpatrickRGreenhallRHymanN (1995) Self-reported functioning and well-being in patients with Parkinson's disease: Comparison of the Short-form Health Survey (SF-36) and the Parkinson's Disease Questionnaire (PDQ-39). Age and Ageing, 24(5), 505–509.
23.
JenkinsonCFitzpatrickRPetoVGreenhallRHymanN (1997) The Parkinson's Disease Questionnaire (PDQ-39): Development and validation of a Parkinson's disease summary index score. Age and Ageing, 26, 353–57.
24.
LoganPAGladmanJRAveryAWalkerMFDyasJGroomL (2004) Randomised controlled trial of an occupational therapy intervention to increase outdoor mobility after stroke. British Medical Journal, 329(7479), 1372–75.
25.
MoherDDulbergCWellsG (1994) Statistical power, sample size, and their reporting in randomised controlled trials. Journal of the American Medical Association, 272(2), 122–24.
26.
MoherDPhamBJonesACookDJJadadARMoherMTugwellPKlassenT (1998) Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?Lancet352(9128), 609–13.
27.
MoherDSchulzKFAltmanDG (2001) The CONSORT statement: Revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet, 357(9263), 1191–94.
28.
RoethlisbergerFHDicksonWJ (1939) Management and the worker. Cambridge, MA: Harvard University Press.
29.
SchragASelaiCJahanshahiMQuinnNP (2000) The EQ-5D — a generic quality of life measure — is a useful instrument to measure quality of life in patients with Parkinson's disease. Journal of Neurology, Neurosurgery and Psychiatry, 69(1), 67–73.
30.
SchulzKFChalmersIHayesRJAltmanDG (1995) Empirical evidence of bias: Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. Journal of the American Medical Association, 273, 408–12.
31.
WadeDTGageHOwenCTrendPGrossmithCKayeJ (2003) Multidisciplinary rehabilitation for people with Parkinson's disease: A randomised controlled study. Journal of Neurology, Neurosurgery and Psychiatry, 74(2), 158–62.
32.
WalkerMFGladmanJRFLincolnNBSiemonsmaPWhiteleyT (1999) Occupational therapy for stroke patients not admitted to hospital: A randomised controlled trial. Lancet, 354(9175), 278–80.
